Glioblastoma (GBM) treatment has remained almost unchanged for more than 20 years. The
current standard of care involves surgical resection (if possible) followed by concomitant …

In addition to the contribution of cancer cells, the solid tumor microenvironment (TME) has a
critical role in determining tumor expansion, antitumor immunity, and the response to …

Immunotherapy continues to be in the spotlight of oncology therapy research in the past few
years and has been proven to be a promising option to modulate one's innate and adaptive …

Eye drops are ophthalmic formulations routinely used to treat dry eye. However, the low
ocular bioavailability is an obvious drawback of eye drops owing to short ocular retention …

Alkali burn is a potentially blinding corneal injury. During the progression of alkali burn‐
induced injury, overwhelmed oxidative stress in the cornea triggers cell damage, including …

Cancer is still a major threat to human life that is characterized by abnormal proliferation and
metastasis of cancer cells. Chemotherapy is procedure of using anti-cancer drugs for …

Chemoimmunotherapy is an emerging paradigm in the clinic for treating several malignant
diseases, such as non-small cell lung cancer, breast cancer, and large B-cell lymphoma …

Cancer nanomedicines and the development of state-of-the-art multifunctional lipid-based
nanoparticles (NPs) has become a fundamental resource in resolving challenging …

Breast cancer (BC) is among the most frequent malignancies women face around the globe.
Nanotherapeutics are constantly evolving to overcome the limitations of conventional …

The anti-metabolite drug gemcitabine is widely used for the treatment of a variety of cancers.
At present, gemcitabine is administered as a hydrochloride salt that is delivered by slow …